ARK Genomic Revolution ETF $ARKG Stock: Global View Capital Management LLC Boosts Stake

Global View Capital Management LLC grew its stake in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 59.0% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 41,424 shares of the company’s stock after buying an additional 15,366 shares during the period. ARK Genomic Revolution ETF makes up 0.5% of Global View Capital Management LLC’s investment portfolio, making the stock its 25th biggest holding. Global View Capital Management LLC owned about 0.09% of ARK Genomic Revolution ETF worth $2,246,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Ascentis Independent Advisors acquired a new stake in ARK Genomic Revolution ETF during the first quarter worth about $26,000. GK Wealth Management LLC acquired a new position in ARK Genomic Revolution ETF in the 3rd quarter valued at approximately $27,000. PNC Financial Services Group Inc. raised its holdings in ARK Genomic Revolution ETF by 53.2% in the 1st quarter. PNC Financial Services Group Inc. now owns 1,088 shares of the company’s stock valued at $29,000 after acquiring an additional 378 shares in the last quarter. Western Wealth Management LLC acquired a new position in ARK Genomic Revolution ETF in the 1st quarter valued at approximately $37,000. Finally, Fifth Third Bancorp bought a new stake in shares of ARK Genomic Revolution ETF in the 1st quarter worth approximately $55,000.

ARK Genomic Revolution ETF Trading Down 6.7%

Shares of ARKG stock opened at $51.40 on Friday. ARK Genomic Revolution ETF has a 12 month low of $24.60 and a 12 month high of $58.83. The stock has a 50 day moving average of $49.92 and a two-hundred day moving average of $37.37.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.